Friday, November 11, 2016

ECTRIMS: Contrasting Popular MS Oral Drugs (CME/CE)

(MedPage Today) -- Enrique Alvarez, MD, PhD, on the tolerability profiles of fingolimod & dimethyl fumarate

No comments:

Post a Comment